Status:
COMPLETED
Gingival Recession Coverage With and Without Emdogain
Lead Sponsor:
University of Bern
Conditions:
Gingival Recession
Emdogain
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Enamel matrix proteins have been shown to play a crucial role during tooth development and its supporting tissues. This is used in periodontal surgery where regeneration of lost tissues around the tee...
Detailed Description
Background Effect of Emdogain on wound healing after gingival recession coverage using connective tissue graft: a pilot study Emdogain Treatment Emdogain (Institute Straumann, Basel Switzerland) is a...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Gingival recession Miller class I and II
- Written informed consent
- Exclusion Criteria
- Patients with a history of a chronic infectious or inflammatory diseases (i.e. rheumatoid arthritis, systemic lupus erythematodes, Crohn's disease, or HIV-, HCV-infection etc.
- Patients with any clinical signs of an acute infection
- Patients with renal failure (GFR \< 30ml/min)
- Smoking \> 5 cigarettes per day
- Patients \< 18 years of age
Exclusion
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 14 2017
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT02230787
Start Date
August 1 2014
End Date
February 14 2017
Last Update
April 20 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Periodontology, University of Bern
Bern, Switzerland, 3010